CNS Therapeutics Markets, 2024: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants & Others - Global Strategic Business Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups:

  • Anti-Alzheimer's
  • Anti-Parkinson's
  • Anti-Epilepsy
  • Pain Management
  • Anti-Psychotics
  • Anti-Depressants
  • Others

The report profiles 162 companies including many key and niche players such as:

  • AbbVie Inc. (USA)
  • Alkermes Plc. (Ireland)
  • Allergan, Plc (Ireland)
  • Amneal Pharmaceuticals, LLC (USA)
  • AstraZeneca Plc (UK)
  • BIAL Group (Portugal)
  • Bristol-Myers Squibb (USA)
  • Eisai Co., Ltd. (Japan)
  • Endo Pharmaceuticals Inc. (USA)
  • Eli Lilly and Co. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fabre-Kramer Pharmaceuticals, Inc. (USA)
  • GlaxoSmithKline (UK)
  • H. Lundbeck A/S (Denmark)
  • Johnson & Johnson (USA)
  • Janssen Pharmaceuticals, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Neurocrine Biosciences, Inc. (USA)
  • Novartis AG (Switzerland)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Pfizer, Inc. (USA)
  • Purdue Pharma L.P. (USA)
  • Sanofi S.A (France)
  • Shire Plc (UK)
  • Strides Shasun Limited (India)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Sunovion Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Co., Ltd. (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • UCB Group (Belgium)

Key Topics Covered:

1. Industry Overview

2. Market Analysis By Therapeutic Categories

3. Growth Drivers & Market Trends

4. Product Overview

5. Innovations

6. Product Introductions/Innovations & R&D Breakthroughs

7. Recent Industry Activity

8. Focus On Select Global Players

9. Global Market Perspective

Total Companies Profiled: 162 (including Divisions

Subsidiaries 183)

  • The United States (79)
  • Canada (13)
  • Japan (15)
  • Europe (50)
    • France (5)
    • Germany (9)
    • The United Kingdom (9)
    • Italy (2)
    • Spain (3)
    • Rest of Europe (22)
  • Asia-Pacific (Excluding Japan) (19)
  • Middle East (4)
  • Latin America (1)
  • Africa (2)

For more information about this report visit https://www.researchandmarkets.com/research/pxpbx4/cns_therapeutics?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs